The utility of SPON1 alone or together with CA-125 [20–27] and/or Human epididymis protein 4 (HE4) [22, 28] should be determined in future experiments using serum samples from patients with ovarian cancer, other benign and malignant tumors, as well as samples from healthy individuals. The gene discussed is SPON1; the disease is ovarian carcinoma.